Optimization of Parkinson's disease therapy with plant extracts and nutrition's evolving roles
- PMID: 38872839
- PMCID: PMC11167367
- DOI: 10.1016/j.ibneur.2024.05.011
Optimization of Parkinson's disease therapy with plant extracts and nutrition's evolving roles
Abstract
Parkinson's disease (PD) is a neurodegenerative disease characterized by death of dopaminergic neurons in the substantia nigra pars compacta (SNpc). Death of dopaminergic cells in the SNpc leads to manifestations of motor dysfunction and non-motor symptoms of PD. The progression of PD symptoms severely affects the quality of life of patients and poses socio-economic problems to families and society at large. The clinical and neuropathological characteristics of PD are triggered by multiple factors such as oxidative stress, neuroinflammation, mitochondrial dysfunction, and protein aggregation. Notwithstanding the advancements in pharmacological therapy in PD management, there is burgeoning interest in alternative and complementary approaches, essentially nutrition and plant extracts strategies. This review gives widespread analysis of the role of nutrition and plant extracts in the management of PD. Studies that investigated the effects of various dietary compounds and plant extract on PD symptoms and progression were reviewed from existing literatures. Nutraceuticals, including vitamins and phytochemicals such as Mucuna pruriens have shown potential neuroprotective functions in preclinical and clinical studies. Indeed, these strategies ameliorate mitochondrial dysfunction, oxidative stress, and neuroinflammation, all which are implicated in the pathogenesis of PD. The neuroprotective mechanisms of nutrition and plant extracts in PD, with emphasis on their capacity to target multiple pathways implicated in PD are discussed. Additionally, challenges and limitations related with translating preclinical findings into clinical practice including standardization of dosing regimens, bioavailability, and inter-individual variability are discussed. Largely, this review elucidates on the role of nutrition and plant extracts as adjunctive therapy in PD management.
Keywords: Flora; Nutrition; Parkinsonism; Parkinson’s disease; Phytotherapy; Substantia nigra.
© 2024 The Authors. Published by Elsevier Inc. on behalf of International Brain Research Organization.
Similar articles
-
Unveiling Nature's potential: Promising natural compounds in Parkinson's disease management.Parkinsonism Relat Disord. 2023 Oct;115:105799. doi: 10.1016/j.parkreldis.2023.105799. Epub 2023 Aug 10. Parkinsonism Relat Disord. 2023. PMID: 37633805 Review.
-
Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.Eur J Med Chem. 2019 May 1;169:185-199. doi: 10.1016/j.ejmech.2019.03.009. Epub 2019 Mar 8. Eur J Med Chem. 2019. PMID: 30877973 Review.
-
Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease.Brain Behav Immun Health. 2020 Mar 18;4:100060. doi: 10.1016/j.bbih.2020.100060. eCollection 2020 Apr. Brain Behav Immun Health. 2020. PMID: 34589845 Free PMC article. Review.
-
Mucuna pruriens Protects against MPTP Intoxicated Neuroinflammation in Parkinson's Disease through NF-κB/pAKT Signaling Pathways.Front Aging Neurosci. 2017 Dec 19;9:421. doi: 10.3389/fnagi.2017.00421. eCollection 2017. Front Aging Neurosci. 2017. PMID: 29311905 Free PMC article.
-
Outcomes of dietary interventions in the prevention and progression of Parkinson's disease: A literature review.AIMS Neurosci. 2024 Dec 30;11(4):520-532. doi: 10.3934/Neuroscience.2024032. eCollection 2024. AIMS Neurosci. 2024. PMID: 39801794 Free PMC article. Review.
Cited by
-
Unveiling the Potential Neuroprotective Effect of Bioactive Compounds from Plants with Sedative and Mood-Modulating Properties: Innovative Approaches for the Prevention of Alzheimer's and Parkinson's Diseases.Curr Neuropharmacol. 2025;23(10):1169-1183. doi: 10.2174/011570159X345397241210103538. Curr Neuropharmacol. 2025. PMID: 39950483 Free PMC article. Review.
-
Comparative efficacy of Mucuna pruriens and conventional levodopa in Parkinson's disease: a randomized controlled trial on pharmacokinetics and clinical perspectives from Asia.J Neural Transm (Vienna). 2025 Mar 26. doi: 10.1007/s00702-025-02914-2. Online ahead of print. J Neural Transm (Vienna). 2025. PMID: 40137945
-
Synergistic Neuroprotective and Immunomodulatory Effects of Cocoa Seed Husk and Guarana Extract: A Nutraceutical Approach for Parkinson's Disease Management.Antioxidants (Basel). 2025 Mar 15;14(3):348. doi: 10.3390/antiox14030348. Antioxidants (Basel). 2025. PMID: 40227469 Free PMC article.
-
Levodopa and Plant-Derived Bioactive Compounds in Parkinson's Disease: Mechanisms, Efficacy, and Future Perspectives.CNS Neurosci Ther. 2025 Aug;31(8):e70540. doi: 10.1111/cns.70540. CNS Neurosci Ther. 2025. PMID: 40808332 Free PMC article. Review.
-
Kalanchoe tomentosa: Phytochemical Profiling, and Evaluation of Its Biological Activities In Vitro, In Vivo, and In Silico.Pharmaceuticals (Basel). 2024 Aug 9;17(8):1051. doi: 10.3390/ph17081051. Pharmaceuticals (Basel). 2024. PMID: 39204156 Free PMC article.
References
-
- Afewerky H.K., Ayodeji A.E., Tiamiyu B.B., Orege J.I., Okeke E.S., Oyejobi A.O., Bate P.N.N., Adeyemi S.B. Critical review of the Withania somnifera (L.) Dunal: ethnobotany, pharmacological efficacy, and commercialization significance in Africa. Bull. Natl. Res. Cent. 2021;45 doi: 10.1186/s42269-021-00635-6. - DOI - PMC - PubMed
-
- Armstrong M.J., Okun M.S. Diagnosis and treatment of Parkinson disease: a review. Jama. 2020;323(6):548–560. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous